ACG clinical guideline: the diagnosis and management of focal liver lesions (Q57150013)

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatic imaging. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Thyroid biopsies: fine-needle aspiration biopsy versus spring-activated core biopsy needle in 102 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Modern diagnosis and management of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

MR imaging of cirrhotic nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cancer surveillance in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Staging cholangiocarcinoma by imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Clinical diagnosis and staging of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Biologic and clinical features of benign solid and cystic lesions of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Clinical features and natural history of hepatocellular adenomas: the impact of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Changing trends in malignant transformation of hepatocellular adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Telangiectatic adenoma: an entity associated with increased body mass index and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Primary liver tumors and oral contraceptives. Results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Pregnancy and liver adenoma management: PALM-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Surgical management of hepatocellular adenoma: take it or leave it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Surgical management of spontaneous ruptured hepatocellular adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Spontaneous hepatic rupture: 13-year experience of a single center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

The malignant transformation of liver cell adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Case-orientated approach to the management of hepatocellular adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Benign hepatic tumours and tumour like conditions in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Sonographically detected hepatic hemangiomas: absence of change over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Benign lesions of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Natural history of hepatic haemangiomas: clinical and ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cavernous hemangiomas of the liver: are there any indications for resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

"Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Depression, anemia and health-related quality of life in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver--a potential mechanism of central scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Association of adenoma and focal nodular hyperplasia: experience of a single French academic center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

On the pathogenesis of focal nodular hyperplasia of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Research on focal nodular hyperplasia with MSCT and postprocessing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Triphasic dynamic CT findings of 63 hepatic focal nodular hyperplasia in 46 patients: correlation with size and pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Management of unresectable symptomatic focal nodular hyperplasia with arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Treatment of symptomatic focal nodular hyperplasia with percutaneous radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Benign focal lesions of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cystic disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

The prevalence of simple renal and hepatic cysts detected by spiral computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Multidetector row CT of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Ultrasound of focal hepatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Natural history and long-term follow-up of antenatally detected liver cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hepatic cysts and liver abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Surgical management and longterm follow-up of non-parasitic hepatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Laparoscopic resection of benign hepatic cysts: a new standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Management of nonparasitic hepatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Symptomatic nonparasitic hepatic cysts: options for and results of surgical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Biochemical and cytologic analysis of cystic contents in benign non-parasitic symptomatic hepatic cysts before and after ethanol sclerotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Surgical management of cystic lesions in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Laparoscopic management of benign nonparasitic hepatic cysts: A prospective nonrandomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Hemorrhagic hepatic cyst: report of a case and review of the literature with emphasis on clinical approach and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Intrahepatic biliary cystic neoplasms: Surgical results of 9 patients and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Ovarian-type stroma in hepatobiliary cystadenomas and pancreatic mucinous cystic neoplasms: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Mucinous biliary cystadenoma with mesenchymal stroma: expressions of CA 19-9 and carcinoembryonic antigen in serum and cystic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Biliary cystadenoma and cystadenocarcinoma.Report of 14 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Management and long-term follow-up of hepatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Surgical management of nonparasitic cystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cystadenoma and cystadenocarcinoma of the liver: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Intrahepatic biliary cystadenoma: a need for radical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Medical and surgical treatment options for polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Autosomal dominant polycystic kidney disease: the last 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Isolated polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Cyst infections in patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

The long-term outcome of patients with polycystic liver disease treated with lanreotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Everolimus in patients with autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Laparoscopic palliation of polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Extended liver resection for polycystic liver disease can challenge liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Liver resection and cyst fenestration in the treatment of severe polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Polycystic liver disease: multimodality imaging for complications and transplant evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Surgical management of polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Treatment response of cystic echinococcosis to benzimidazoles: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Classification of hydatid liver cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Percutaneous Aspiration-Injection-Reaspiration Drainage Plus Albendazole or Mebendazole for Hepatic Cystic Echinococcosis: A Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

RF-assisted cystectomy and pericystectomy: a new technique in the treatment of liver hydatid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Results of surgical, laparoscopic, and percutaneous treatment for hydatid disease of the liver: 10 years experience with 355 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Liver hydatid disease: radiofrequency-assisted pericystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Percutaneous drainage compared with surgery for hepatic hydatid cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Predictors of morbidity and mortality in the surgical management of hydatid cyst of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Laparoscopic treatment of hepatic hydatid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Management of cystic echinococcosis complications and dissemination: where is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213

Treatment options for hepatic cystic echinococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.213